Stockscreener 앱 받기
0.0162
20.52%
-0.0106
시간 외 거래:
.02
0.00376
+23.15%
전일 마감가:
$0.0268
열려 있는:
$0.0175
하루 거래량:
31,733
Relative Volume:
119.12
시가총액:
$N/A
수익:
-
순이익/손실:
$-43.29M
주가수익비율:
-0.0148
EPS:
-1.1
순현금흐름:
$-34.80M
1주 성능:
-20.52%
1개월 성능:
-94.35%
6개월 성능:
-97.62%
1년 성능:
-98.31%
1일 변동 폭
$0.0154
$0.0175
1주일 범위
$0.0154
$0.0175
52주 변동 폭
$0.0154
$0.0175
Viracta Therapeutics Inc Stock (VIRX) Company Profile
VIRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VIRX
Viracta Therapeutics Inc
|
0.0162 | 0 | 0 | -43.29M | -34.80M | -1.10 |
|
VRTX
Vertex Pharmaceuticals Inc
|
459.62 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.36 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
331.91 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
543.48 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
245.49 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Viracta Therapeutics Inc Stock (VIRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-16 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2022-02-01 | 개시 | RBC Capital Mkts | Outperform |
| 2021-05-03 | 개시 | H.C. Wainwright | Buy |
| 2021-04-26 | 개시 | SVB Leerink | Outperform |
| 2021-03-25 | 개시 | Evercore ISI | Outperform |
Viracta Therapeutics Inc 주식(VIRX)의 최신 뉴스
Fierce Biotech Layoff Tracker 2025: Relay sheds staff again; Sail lays off employees - Fierce Biotech
Layoff Tracker: BioAtla Streamlines Operations By Cutting 30% of Staff - BioSpace
Viracta Therapeutics (VIRX) to Release Quarterly Earnings on Thursday - Defense World
Calif. biotech company once worth $476M lays off every remaining employee - MSN
Viracta Therapeutics, Inc. (NASDAQ:VIRX) Sees Significant Decrease in Short Interest - Defense World
Semler Scientific (SMLR) Projected to Post Earnings on Tuesday - Defense World
Viracta Therapeutics to cease operations and seek alternatives - MSN
Finance Watch: Third Harmonic, Q32 Bio Cut Jobs To Focus On Lead Assets - insights.citeline.com
Procaps Group (NASDAQ:PROC) vs. Viracta Therapeutics (NASDAQ:VIRX) Financial Comparison - Defense World
🔬 Latest pharma industry updates 👇 - substack.com
VIRX stock plunges to 52-week low, touches $0.08 - MSN
Viracta Therapeutics Terminates Employees & Winds Down Operations - Contract Pharma
Viracta Winds Down Business, Unable to Weather Financial Troubles - BioSpace
Viracta Therapeutics Announces Wind Down of Operations - GlobeNewswire
Viracta Therapeutics to cease operations and seek alternatives By Investing.com - Investing.com South Africa
Viracta Therapeutics Announces Wind Down Of Operations - marketscreener.com
Viracta Therapeutics hits end of the line, laying off all workers and winding down - Fierce Biotech
Viracta Therapeutics Announces Wind-Down and Leadership Changes - TipRanks
Viracta Therapeutics Winds Down Operations, Terminates Employees - MarketWatch
Leerink Partners slashes price target on Viracta Therapeutics Inc [VIRX] – find out why. - The DBT News
Views of Wall Street’s Leading Experts on Viracta Therapeutics Inc - SETE News
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
VIRX’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle
Analyzing VIRX’s price-to-book ratio for the last quarter - US Post News
Viracta Therapeutics to be delisted from Nasdaq - MSN
Pre-market Movers: SLGL, VIRX, ANVS, CUTR... - RTTNews
Viracta Therapeutics Inc (VIRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.68%
0.50%
자본화:
|
볼륨(24시간):